Article Details
Retrieved on: 2018-01-31 04:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc increased Valeant Pharmaceuticals Intl (VRX) stake by 4.91% reported in 2017Q3 SEC filing. <b>Vanguard Group</b> Inc acquired 356,925 shares as Valeant Pharmaceuticals Intl (VRX)'s stock declined 15.71%. The <b>Vanguard</b> <b>Group</b> Inc holds 7.63 million shares with $109.36M value, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here